Literature DB >> 30674547

Empagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Left Ventricular Hypertrophy: A Subanalysis of the EMPA-REG OUTCOME Trial.

Subodh Verma1, C David Mazer2, Deepak L Bhatt3, Satish R Raj4,5, Andrew T Yan6, Atul Verma7, Ele Ferrannini8, Gudrun Simons9, Jisoo Lee9, Bernard Zinman10, Jyothis T George9, David Fitchett6.   

Abstract

Entities:  

Year:  2019        PMID： 30674547     DOI： 10.2337/dc18-1959

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  8 in total

Review 1.  Clinical Evidence and Proposed Mechanisms of Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: A Class Effect?

Authors:  Brent Deschaine; Sahil Verma; Hussein Rayatzadeh
Journal:  Card Fail Rev       Date:  2022-06-29

Review 2.  Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

Review 3.  Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: a review of the literature with a focus on SGLT2 inhibitors.

Authors:  Mouhamed Nashawi; Omar Sheikh; Ayman Battisha; Abdullah Ghali; Robert Chilton
Journal:  Heart Fail Rev       Date:  2020-11-09       Impact factor: 4.214

Review 4.  Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function.

Authors:  Volker Vallon; Subodh Verma
Journal:  Annu Rev Physiol       Date:  2020-11-16       Impact factor: 19.318

Review 5.  Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention.

Authors:  Mohapradeep Mohan; Adel Dihoum; Ify R Mordi; Anna-Maria Choy; Graham Rena; Chim C Lang
Journal:  Front Cardiovasc Med       Date:  2021-09-29

Review 6.  Cardiovascular outcomes trials: a paradigm shift in the current management of type 2 diabetes.

Authors:  Melanie J Davies; Heinz Drexel; François R Jornayvaz; Zoltan Pataky; Petar M Seferović; Christoph Wanner
Journal:  Cardiovasc Diabetol       Date:  2022-08-04       Impact factor: 8.949

7.  Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention.

Authors:  Seyed Mohammad H Adel; Fateme Jorfi; Hoda Mombeini; Homeira Rashidi; Saad Fazeli
Journal:  Saudi Med J       Date:  2022-05       Impact factor: 1.422

8.  Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.

Authors:  Line Reinholdt Pedersen; Anna Meta Dyrvig Kristensen; Søren Sandager Petersen; Muthiah Vaduganathan; Deepak L Bhatt; Jacob Juel; Christina Byrne; Margrét Leósdóttir; Michael H Olsen; Manan Pareek
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-19       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.